Citafine 1gm

Gemcitabine sold under the brand name Citafine and it is a chemotherapy medication required to treat several types of cancer. Citafine 1gm administered into a vein by slow injection.
Citafine 1gm is a prescription drug which is used under the supervision of medical oncologist

Gemcitabine

Citafine

1gm

Emcure




Indication

Citafine 1gm is indicated for the treatment of following conditions :
• Pancreas cancer
• Non-small cell lung cancer
• Bladder cancer
• Soft-tissue sarcoma
• Metastatic breast cancer
• Ovarian cancer

Mechanism of action

Antimetabolites inhibits the DNA production. This discontinue cell growth and division, reporting in the reducing or blocking of cancer growth. Since cancer cells, in general, replicate faster and with less error-correcting than healthy cells, cancer cells are more conscious to this damage.
Gemcitabine kills cancer cells go through DNA synthesis. It interferes with ribonucleotide reductase, an enzyme important to DNA combination. Because cells cannot duplicate their DNA, they cannot properly multiply, and thus die.



Pharmacokinetics

By infusion length the volume of distribution is increased Vd: 50 L/m2

Transformed through nucleoside kinases to two active metabolites such as gemcitabine diphosphate and gemcitabine triphosphate

The drug is excreted through urine (92-98%) and Half-life of Citafine is 1.7-19.4 hr


Blueberrypharma.com-img1

drug
Brand Citafine
Ingredients Gemcitabine
Strength 1gm
Manufactured Emcure
Rating

Pancreatic cancer :
The recommended dose is 1000mg/m2 IV infusion over 30 min once weekly x 7 weeks; rest 1 week And the dose 1000mg/m2IV once weekly for 3 weeks of each 28-day cycle Non-small cell lung cancer :
The recommended dose is 1000mg/m2IV infusion over 30 minutes on days 1,8 and 15 of each 28-day cycle or The recommended dose is 1250 mg/m2IV over 30 minutes on days 1 and 8 of each 21-day cycle Administer cisplatin 100mg/m2 IV after gemcitabine on day 1 Breast cancer :
The recommended dose is 1250 mg/m2IV over 30 minutes on days 1 and 8 of each 21-day cycle Dose with paclitaxel 175mg/m2 on day 1 as a 3-hr infusion before gemcitabine Ovarian cancer :
The recommended dose is 1000 mg/m2IV over 30 minutes on days 1 and 8 of each 21-day cycle. Dose with carboplatin AUC 4 on day 1 after gemcitabine

Very common side effects :
• Dyspnea.
• Alopecia
• Allergic skin rash or itching.
• Cold or flu-like symptoms.
• Retention of fluid in the body
• Abnormal results in liver function tests.
• blood in the urine or protein presence
Common side effects :
• Loss of appetite.
• Headache.
• Insomnia
• Sleepiness.
• Mouth ulcers.
• Diarrhoea or constipation.
• Cough.
• Blocked or runny nose.
• Sweating.
• Back pain.
• Aching muscles (myalgia).
• Chills and fever.
• Weakness

Precaution

While treatment with Citafine 1gm will causes Myelosuppression.
When Citafine 1gm in combination with carboplatin or paclitaxel: patients should have ANC >1.5 x 10^6/mL and platelet count >10^8/mL prior to each cycle
With Citafine 1gm treatment Capillary leak syndrome resulted with serious consequences; discontinue if symptoms occur
Haemolytic uremic syndrome resulted, containing fatalities; permanently stop treatment in patients with HUS or serious kidney impairment; Kidney failure may not be reversible even with stop of therapy
Drug-induced liver injury resulted, involving liver failure and death; assess hepatic function before to initiation of therapy and periodically during treatment; stop drug in patients which develop severe liver injury

DRUG INTERACTION

  • No drug interaction studies have been conducted

Contraindication

Hypersensitivity



The Citafine 1gm Pregnancy category D
When administrated to a pregnant woman will cause fetal harm to the fetus the pregnant women should be apprised of the possible hazard to a fetus.

Avoid breastfeed during this treatment because the drug Citafine 1gm may excreted into breast milk

The drug Citafine 1gm Store at 20°C to 25°C (68°F to 77°F)

Blueberrypharma.com-img2



Quick Contact




Prescription upload






PRESCRIPTION


Blueberrypharma.com , a fully licensed and regulated pharmacy medicine, takes all precautions to strictly abide by the laws and regulations set forth in the dispensing of prescription medications. By placing the order for your prescription medicines, you acknowledge and accept the following terms regarding the purchase of any prescription medicines.

Blueberrypharma.com will not dispense any prescription medication without a valid prescription from a licensed physician.

If you are ordering prescription medication(s), you hereby confirm that you will send us a scanned copy of your valid prescription(s) via email, fax, Whatsapp, or by post, and this prescription shall then be subject to the scrutiny of and approval by our qualified Pharmacists.

The drug information provided in the Blueberrypharma.com is for informative purposes only and this Website is not intended to provide diagnosis, treatment or medical advice. We are not liable for any adverse effects or harm to you as a result of your reliance on the information in the Website.

Blueberrypharma.com requires either the User or Customer or the Caregiver to confirm he/she is completely aware of the indications, side effects, drug interactions, effects of missed dose or overdose of the medicines he/she orders from us. It is imperative to seek professional advice from your physician before purchasing or consuming any medicine from Blueberrypharma.com

At Blueberrypharma.com , a Caregiver can order prescription medicines on your behalf.